| Lin, Yin-Ku |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Chung, Wen-Hung |
| Recruiting | 3 | 1300 | Europe, Canada, Japan, US, RoW | TAK-279 | Takeda | Plaque Psoriasis | 05/26 | 05/26 | | |
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata |
|
|
| Recruiting | 3 | 595 | Europe, Canada, Japan, US, RoW | Baricitinib, LY3009104, Placebo | Eli Lilly and Company | Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical | 09/24 | 08/29 | | |
NCT06088043: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment |
|
|
| Active, not recruiting | 3 | 693 | Europe, Canada, Japan, US, RoW | TAK-279, Placebo, Apremilast | Takeda | Plaque Psoriasis | 08/25 | 04/26 | | |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Wu, Jennifer M |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma |
|
|
| Active, not recruiting | 2 | 134 | US, RoW | SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo | Coherus Biosciences, Inc. | Hepatocellular Carcinoma | 05/25 | 05/26 | | |
| Completed | N/A | 120 | US | Catheter removal | University of North Carolina, Chapel Hill | Urinary Retention Postoperative, Patient Satisfaction | 07/22 | 09/22 | | |
| Completed | N/A | 147 | US | Gynecare TVT Exact Continence System, Midurethral sling, Neomedic KIM (Knotless Incontinence Mesh) | University of North Carolina, Chapel Hill | Stress Urinary Incontinence | 05/23 | 06/24 | | |
| Active, not recruiting | N/A | 271 | US | Biofeedback, Injection | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of North Carolina, Chapel Hill, Colon and Rectal Surgery Associates, Ltd., Augusta University, RTI International, University of Alabama at Birmingham, University of Michigan | Fecal Incontinence, Bowel Incontinence | 05/24 | 12/25 | | |
| Recruiting | N/A | 68 | US | Perineal massage | University of North Carolina, Chapel Hill | Prolapse, Vaginal, Stress Urinary Incontinence, Pessaries, Pain | 08/25 | 08/25 | | |
NCT03496051: Single Patient Access (Compassionate Use) for Continued Treatment of RO7070179 for Adult Subjects With Advanced Hepatocellular Carcinoma (HCC) |
|
|
| Available | N/A | | US | RO7070179 | New York University School of Medicine, Roche-Genentech | Hepatocellular Carcinoma | | | | |
| Shih, I-Hsin |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Yang, Chin-Yi |
ADorable-1, NCT05559359: A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 360 | Europe, Canada, Japan, US, RoW | Lebrikizumab, LY3650150, DRM06, Placebo, Topical Corticosteroid (TCS) | Eli Lilly and Company, Dermira, Inc. | Atopic Dermatitis, Eczema | 05/25 | 09/25 | | |
ADorable-2, NCT05735483: A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis |
|
|
| Enrolling by invitation | 3 | 310 | Europe, Canada, Japan, US, RoW | Lebrikizumab, LY3650150, Placebo | Eli Lilly and Company | Atopic Dermatitis, Eczema | 06/26 | 06/26 | | |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
NCT05911841: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis |
|
|
| Active, not recruiting | 2 | 236 | Europe, Canada, Japan, US, RoW | LY3454738, Placebo | Eli Lilly and Company | Atopic Dermatitis | 06/25 | 03/26 | | |
| Shaw, Steven SW |
| Completed | N/A | 42454 | Japan, RoW | Low-dose aspirin in women with high risk of preeclampsia | Chiu Yee Liona Poon | Pre-Eclampsia | 06/23 | 08/23 | | |
| Chen, Chun-Bing |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
NCT04369846: A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients |
|
|
| Recruiting | 1/2 | 102 | RoW | GM-XANTHO onitment, Drawing blood, Placebo onitment | Xantho Biotechnology Co., LTD, Virginia Contract Research Organization Co., Ltd. | Atopic Dermatitis | 12/24 | 06/25 | | |
| Lu, Chun-Wei |
NCT04908657: Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation |
|
|
| Recruiting | 4 | 40 | RoW | Sildenafil 20 MG | National Taiwan University Hospital | Liver Fibrosis | 07/23 | 12/23 | | |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Chiu, Chih-Yung |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Su, Shih-Chi |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| See, Lai-Chu |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Chi, Min-Hui |
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis |
|
|
| Completed | 2 | 22 | RoW | Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1% | Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan | Atopic Dermatitis | 12/21 | 12/21 | | |
| Hung, Tai-Ho |
| No trials found |
